Cited by 44Cancer therapeutics and mechanismsCancer Cells and MetastasisBioactive Compounds and Antitumor Agents

Effects of cell density on drug-induced cell kill kinetics in vitro (inoculum effect)

Open access
Ohnuma, T, Arkin, H, Holland, J F·1986·British Journal of Cancer

Abstract

The effects of cell density on drug-induced cell kill kinetics were studied by means of clonogenic assay using 3 human leukaemia-lymphoma cell lines. Mitoxantrone, daunorubicin, doxorubicin, vincristine and bleomycin were progressively less efficacious when cell density increased (positive inoculum effects), whereas the effects of cis-platin and carboplatin were not influenced by cell density. Inoculum effects were related to the kind of chemotherapeutic agents tested, irrespective of the type of cell lines used. Preincubation of mitoxantrone or doxorubicin in the presence of cells in high density resulted in decreases in the cytocidal activity, whereas the effects of bleomycin, vincristine and cis-platin were unaffected. These results show that cell density affects the biological effect of certain chemotherapeutic agents. Inactivation of drugs by high densities of cells partially explains this phenomenon.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjc.1986.192

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The density of eukaryotic cells can have a profound influence on the outcome of toxicological studies.

    “it soon became apparent that the density of eukaryotic cells can have a profound influence on the outcome of toxicological studies (Ohnuma et al., 1986; Brook, 1989; Schildknecht et al., 2009; Schildknecht et al., 2011; Scholz et al., 2011).”

    From In Vitro research Reproducibility: Keeping up High Standards (2019) · cites this paper as Ohnuma et al., 1986

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited by

Sorted by citations

Authors
Ohnuma, T., Arkin, H., & Holland, J. F.
Venue
British Journal of Cancer
Published
1986-09
Volume
54
Issue
3
Pages
415-421
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W1993176032
Cited by
44
References
0
Citations by year
2026: 1 · 2023: 1 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2012: 1
FWCI
0.98
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (CA 15936, CA-25865)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Keywords
inoculum effect, cell density, clonogenic assay, mitoxantrone, daunorubicin, doxorubicin, vincristine, bleomycin, cisplatin, carboplatin, anticancer agents
MeSH terms
Antineoplastic Agents, Bleomycin, Burkitt Lymphoma, Cell Count, Cell Survival, Cisplatin, Daunorubicin, Dose-Response Relationship, Drug, Doxorubicin, Humans, Leukemia, Lymphoid, Leukemia, Myeloid, Mitoxantrone, Organoplatinum Compounds, Vincristine, Carboplatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review